| ★ | COMP360 Psilocybin's 26-Week Data in Treatment-Resistant Depression I Boadie Dunlop, MD | | 178 | Estados Unidos | |
| 17 | Furoscix ReadyFlow (Furosemide) and its Impact on HF, CKD Edema Treatment | | 374 | Estados Unidos | 66 |
| 16 | Inhaled Treprostinil for IPF: TETON-1 Phase 3 Results With Steven Nathan, MD | ATS 2026 | | 301 | Estados Unidos | 66 |
| 5 | What Comes Next for PORT-77 as It Heads Toward Phase 2b/3? | | 196 | Estados Unidos | 69 |
| 12 | Continuous Glucose Monitoring in Type 2 Diabetes, With John Anderson, MD | | 196 | Estados Unidos | 67 |
| 14 | All 12 Tegoprubart Recipients Off External Insulin Following Islet Implant in Pilot Study | | 168 | Estados Unidos | 66 |
| 4 | Highlighting FDA-Approved Therapies in Atopic Dermatitis, With Chris Bunick, MD, PhD | | 152 | Estados Unidos | 69 |
| 7 | New Martin-Hopkins LDL-C-Estimating Equation Simplifies Implementation for Comparable Results | | 151 | Estados Unidos | 68 |
| 6 | Mepolizumab Reduced COPD Hospitalizations in Eosinophilic Disease | ATS 2026 With Gerard Criner, MD | | 113 | Estados Unidos | 68 |
| 1 | Brensocatib, 1 Year Later: Who Benefits Most? | Mark Metersky, MD | | 98 | Estados Unidos | 71 |
| 18 | SUNRISE: Tezepelumab Shows Meaningful OCS Reduction in Severe Asthma | | 78 | Estados Unidos | 66 |
| 15 | Omalizumab vs Oral Immunotherapy for Multifood Allergy | | 65 | Estados Unidos | 66 |
| 8 | Addressing Advances and Roadblocks in Lipid Management, With Joseph Saseen, PharmD | | 64 | Estados Unidos | 68 |
| 13 | POCUS is Standard of Care in Critical Care, With Rhea Votipka, NP | | 35 | Estados Unidos | 67 |
| 20 | FMD Peak Systolic Velocity May Lead to Comprehensive Clinical Guidelines | | 33 | Estados Unidos | 65 |
| 9 | Diagnosing Non-IgE Food Hypersensitivity | Brian Lacy, MD, PhD | EAC 2026 | | 31 | Estados Unidos | 67 |
| 10 | Pegtarazimod Cuts Oxygen Need in Hospitalized COPD Patients | ATS 2026 | Gerald Criner, MD | | 29 | Estados Unidos | 67 |
| 2 | Addressing the Manifold Barriers in Hypertension, With Michael Miedema, MD | | 27 | Estados Unidos | 71 |
| 19 | Brief, Regular Movement Breaks Can Improve Cardiovascular Risk in T2D | | 24 | Estados Unidos | 65 |
| 11 | IBS-C Treatment Cycling Linked to Higher Healthcare Utilization | | 23 | Estados Unidos | 67 |
| 3 | Abdominal Pain and Bloating: Recognizing HAE, MCAS, and Eosinophilic GI Disorders | Brian Lacy, MD | | 20 | Estados Unidos | 70 |